High uric acid is the direct cause of gout. When uric acid in your blood exceeds roughly 6.8 mg/dL, it crosses a solubility threshold and can form needle-shaped crystals inside your joints. These crystals trigger the intense inflammation that defines a gout attack. That said, not everyone with high uric acid develops gout, and the path from elevated levels to a painful flare involves several steps worth understanding.
How Uric Acid Becomes Crystals
Uric acid is a normal byproduct of breaking down purines, compounds found in your cells and in foods like red meat, shellfish, and alcohol. At typical body temperature and blood pH, uric acid dissolves easily in your blood and joint fluid. The trouble starts when concentrations rise above about 6.8 mg/dL. At that point, the solution becomes supersaturated, meaning it holds more uric acid than it can keep dissolved.
Once supersaturation occurs, uric acid molecules begin clustering together in a process called nucleation. These clusters grow into monosodium urate crystals, the tiny, sharp structures that deposit in joints and surrounding soft tissue. Nucleation is the slowest step in crystal formation, which is one reason it can take years of high uric acid before a first gout attack happens.
Temperature and acidity speed the process up. A drop of just 2°C, from normal body temperature to the temperature of a cooler joint like the big toe, lowers the solubility threshold from 6.8 to 6.0 mg/dL. That’s a big part of why gout so often strikes the big toe and other extremities: they’re the coldest spots in the body, and crystals form there more readily. Acidic conditions in the joint fluid also promote crystallization through both direct effects on crystal formation and indirect effects on local calcium levels.
Why the Immune System Overreacts
The crystals themselves don’t cause pain directly. The agony of a gout flare comes from your immune system’s response to them. When white blood cells encounter urate crystals in a joint, they activate an internal alarm system that triggers the release of a powerful inflammatory signal called IL-1 beta. This cascade produces the redness, heat, swelling, and extreme tenderness that can make even the weight of a bedsheet unbearable.
The inflammatory response is essentially the same mechanism your body uses against invading bacteria. Your immune system treats the crystals as foreign objects and mounts a full-scale attack. This is why gout flares come on so suddenly and intensely, often peaking within 12 to 24 hours.
High Uric Acid Doesn’t Always Mean Gout
Here’s the nuance most people miss: the majority of people with high uric acid never get gout. In a large retrospective study following patients for an average of 7.5 years, only about 3% of people with hyperuricemia developed gout during that period. Among people with normal uric acid levels, just 0.1% did. So elevated uric acid dramatically increases your risk, but it’s far from a guarantee.
Doctors generally define hyperuricemia as levels above 6 mg/dL in women and 7 mg/dL in men, with readings of 8 mg/dL or higher considered clearly elevated. But the biologically meaningful number is 6.8 mg/dL, the saturation point where crystal formation becomes possible regardless of sex. You can sit above that threshold for years, accumulating crystal deposits silently, before something tips the balance toward an actual flare.
What Pushes Uric Acid Levels Up
Your kidneys handle 60 to 70% of all uric acid removal from the body, filtering it from the blood and excreting it in urine. Normally, about 90% of filtered uric acid gets reabsorbed back into the bloodstream, with only around 10% making it into urine. Any disruption to this tightly controlled system, whether from kidney disease, certain medications, or genetic differences, can tip the balance toward accumulation.
Genetics play a meaningful role. Large-scale genetic studies have identified several genes that regulate how your body handles uric acid. Two of the most influential are SLC2A9, which codes for a urate transporter in the kidneys, and ABCG2, which helps excrete uric acid through both the kidneys and the gut. Variants in these genes are strongly associated with higher uric acid levels and increased gout risk across multiple ethnic populations. This is why gout often runs in families.
Beyond genetics, the usual suspects matter: diets high in purines (organ meats, certain seafood, beer), obesity, chronic kidney disease, and metabolic syndrome all raise uric acid levels. Dehydration concentrates uric acid in the blood, and some common medications like certain diuretics reduce the kidneys’ ability to clear it.
What Triggers a Flare
If crystals have been quietly depositing in your joints for months or years, a flare often needs a trigger. A purine-rich meal or a night of heavy drinking can spike uric acid and provoke an attack. But counterintuitively, a rapid drop in uric acid can also trigger a flare. When uric acid levels fall quickly, existing crystal deposits can partially dissolve and break apart, exposing fresh crystal surfaces to immune cells and setting off inflammation.
This is why people sometimes experience gout attacks when they first start urate-lowering treatment, or after bariatric surgery (which causes an initial spike in uric acid followed by a gradual decline over weeks to months). It’s not the absolute level that always matters most. Fluctuations in either direction can destabilize crystal deposits and provoke the immune response.
Lowering Uric Acid to Prevent Attacks
Because uric acid is the root cause, long-term gout management focuses on getting levels low enough to dissolve existing crystals and prevent new ones from forming. The American College of Rheumatology strongly recommends a target of below 6 mg/dL for anyone on urate-lowering therapy. That’s deliberately below the 6.8 mg/dL saturation point, providing a buffer that allows gradual dissolution of crystal deposits over time.
Treatment typically starts at a low dose and gets adjusted upward based on repeated blood tests, a “treat-to-target” approach similar to how blood pressure or cholesterol management works. The goal isn’t just to reduce flares but to keep uric acid consistently below target so crystals slowly disappear from the joints altogether. For people with visible tophi (chalky deposits under the skin), radiographic joint damage, or frequent flares, starting this therapy is strongly recommended rather than optional.
Reaching target doesn’t happen overnight. It can take months to years of sustained low uric acid levels to fully dissolve accumulated deposits, and flares may actually increase temporarily during the early phase of treatment as crystals break down. This is a normal part of the process, not a sign that treatment is failing.